Insights on Investing in KDP – Analyst Recommendations

By Ken Smith • Wednesday, January 29 15:11 • Permanent Link

Keurig Dr Pepper logged a 1.8% change during today's afternoon session, and is now trading at a price of $31.89 per share. The S&P 500 index moved -0.0%. KDP's trading volume is 4,991,589 compared to the stock's average volume of 10,166,796.

Keurig Dr Pepper trades -13.71% away from its average analyst target price of $36.95 per share. The 20 analysts following the stock have set target prices ranging from $32.1 to $42.0, and on average have given Keurig Dr Pepper a rating of buy.

If you are considering an investment in KDP, you'll want to know the following:

Keurig Dr Pepper's current price is 26.5% above its Graham number of $25.21, which implies that at its current valuation it does not offer a margin of safety
Keurig Dr Pepper has moved -0.3% over the last year, and the S&P 500 logged a change of 25.2%
Based on its trailing earnings per share of 1.66, Keurig Dr Pepper has a trailing 12 month Price to Earnings (P/E) ratio of 19.2 while the S&P 500 average is 29.3
KDP has a forward P/E ratio of 15.6 based on its forward 12 month price to earnings (EPS) of $2.05 per share
Its Price to Book (P/B) ratio is 1.73 compared to its sector average of 3.3
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally.
Based in Burlington, the company has 28,100 full time employees and a market cap of $43.26 Billion. Keurig Dr Pepper currently returns an annual dividend yield of 2.8%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.